![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:DBP-PTTG1IP (FusionGDB2 ID:HG1628TG754) |
Fusion Gene Summary for DBP-PTTG1IP |
![]() |
Fusion gene information | Fusion gene name: DBP-PTTG1IP | Fusion gene ID: hg1628tg754 | Hgene | Tgene | Gene symbol | DBP | PTTG1IP | Gene ID | 1628 | 754 |
Gene name | D-box binding PAR bZIP transcription factor | PTTG1 interacting protein | |
Synonyms | DABP|taxREB302 | C21orf1|C21orf3|PBF | |
Cytomap | ('DBP')('PTTG1IP') 19q13.33 | 21q22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | D site-binding proteinD site of albumin promoter (albumin D-box) binding proteinalbumin D box-binding proteinalbumin D-element-binding proteintax-responsive enhancer element-binding protein 302 | pituitary tumor-transforming gene 1 protein-interacting proteinPTTG-binding factorpituitary tumor-transforming 1 interacting proteinpituitary tumor-transforming gene protein-binding factor | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q10586 | . | |
Ensembl transtripts involved in fusion gene | ENST00000222122, ENST00000601104, ENST00000593500, ENST00000599385, | ||
Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 8 X 9 X 4=288 |
# samples | 4 | 11 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/288*10)=-1.38856528791765 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: DBP [Title/Abstract] AND PTTG1IP [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | DBP(49138836)-PTTG1IP(46281186), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | DBP-PTTG1IP seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. DBP-PTTG1IP seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | DBP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20093779 |
Tgene | PTTG1IP | GO:0006606 | protein import into nucleus | 10781616 |
Tgene | PTTG1IP | GO:0031398 | positive regulation of protein ubiquitination | 24506068 |
Tgene | PTTG1IP | GO:1903364 | positive regulation of cellular protein catabolic process | 24506068 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | THCA | TCGA-DJ-A3V5 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
Top |
Fusion Gene ORF analysis for DBP-PTTG1IP |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000222122 | ENST00000494690 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
5CDS-5UTR | ENST00000601104 | ENST00000494690 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
5CDS-intron | ENST00000222122 | ENST00000397886 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
5CDS-intron | ENST00000222122 | ENST00000445724 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
5CDS-intron | ENST00000601104 | ENST00000397886 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
5CDS-intron | ENST00000601104 | ENST00000445724 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
Frame-shift | ENST00000222122 | ENST00000330938 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
Frame-shift | ENST00000222122 | ENST00000397887 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
Frame-shift | ENST00000601104 | ENST00000330938 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
Frame-shift | ENST00000601104 | ENST00000397887 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-3CDS | ENST00000593500 | ENST00000330938 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-3CDS | ENST00000593500 | ENST00000397887 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-3CDS | ENST00000599385 | ENST00000330938 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-3CDS | ENST00000599385 | ENST00000397887 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-5UTR | ENST00000593500 | ENST00000494690 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-5UTR | ENST00000599385 | ENST00000494690 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-intron | ENST00000593500 | ENST00000397886 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-intron | ENST00000593500 | ENST00000445724 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-intron | ENST00000599385 | ENST00000397886 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
intron-intron | ENST00000599385 | ENST00000445724 | DBP | chr19 | 49138836 | - | PTTG1IP | chr21 | 46281186 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for DBP-PTTG1IP |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for DBP-PTTG1IP |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:49138836/:46281186) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
DBP | . |
FUNCTION: This transcriptional activator recognizes and binds to the sequence 5'-RTTAYGTAAY-3' found in the promoter of genes such as albumin, CYP2A4 and CYP2A5. It is not essential for circadian rhythm generation, but modulates important clock output genes. May be a direct target for regulation by the circadian pacemaker component clock. May affect circadian period and sleep regulation. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for DBP-PTTG1IP |
![]() |
Top |
Fusion Gene PPI Analysis for DBP-PTTG1IP |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DBP-PTTG1IP |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for DBP-PTTG1IP |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |